Sign inJoin waitlistJoin the waitlist

Thomas Galloway

Chief, Division of Head and Neck Radiation Oncology · Temple University Hospital

Credentials: · · · · ·

History

Division of Head and Neck Radiation Oncology · Temple University Hospital
Present
Clinical Research · Temple University Hospital
Present
Temple University Hospital
Present

Radiation Oncology
University of Florida College of Medicine
2006–2010
Preliminary or Transitional Year
2005–2006
University of Florida College of Medicine
2001–2005

Research

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2020 · 1,128 citations
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
The Lancet · 2019 · 1,066 citations
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
Journal of the National Comprehensive Cancer Network · 2022 · 456 citations

JR
John Ridge
39 papers
Jeffrey Liu
17 papers
Miriam Lango
15 papers
Ranee Mehra
15 papers
Jessica Bauman
13 papers
Sue Yom
13 papers
Barbara Burtness
12 papers
MG
Maura Gillison
12 papers
JC
Jimmy Caudell
10 papers
CJ
Christopher Jones
7 papers
Dimitrios Colevas
7 papers
Robert Amdur
7 papers

Clinical trials

Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer
Principal investigator · Recruiting · Phase 2
Fox Chase Cancer Center
2023–2027
Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function
Principal investigator · Terminated · Phase 2
Fox Chase Cancer Center
2015–2018
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2021–2029
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Site PI · Recruiting · Phase 2
ECOG-ACRIN Cancer Research Group
2016–2027